Skip to content

Study on the mechanism of action of visual feedback strategy in virtual reality rehabilitation technology on upper limb motor function and cognitive function

Study on the mechanism of action of visual feedback strategy in virtual reality rehabilitation technology on upper limb motor function and cognitive function

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066605
Enrollment
Unknown
Registered
2022-12-12
Start date
2022-12-12
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Healthy People Movement Full Immersion Group:Full Immersion VR sports training
Healthy people movement semi-immersion group:Semi-immersive VR sports training
Healthy people cognition full-immersion group:Full-immersive VR cognition training
Healthy people cognition semi-immersion group:Semi-immersive VR cognition training
Stroke Movement Full Immersion Group:Full Immersion VR sports training
Stroke movement semi-immersion group:Semi-immersive VR sports training
Stroke cognition full-immersion group:Full-immersive VR cognition training
Stroke cognition semi-immersion group:Semi-immersive VR cognition training

Sponsors

The Third Affiliated Hospital of Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Healthy Subjects. Inclusion criteria:(1) Participants had no personal or family history of neuropsychiatric disorders, were not on medication, and were all right-handed. (2) 18 years = age = 60 years. (3) no history of alcohol abuse or conditions that affect mental and cognitive performance such as late nights. (4) No history of epilepsy. (5) Signed informed consent form. Stroke patients. Inclusion criteria: (1) First stroke, confirmed by cranial CT or MRI. (2) Onset of stroke between two weeks and six months. (3) Presence of upper extremity motor dysfunction or cognitive impairment.

Exclusion criteria

Exclusion criteria: Healthy Subjects. Exclusion criteria: (1) Those with other neurological disorders that affect cognitive function. (2) Those with emotional or psychological disorders that affect cognitive function. (3) Those with comprehension impairment, visual impairment, hearing impairment, complete aphasia, and severe cognitive impairment. (4) Patients who are receiving other clinical central nervous interventions. Stroke patients. Exclusion criteria: (1) history of previous stroke, history of traumatic brain injury, history of brain tumor. (2) Complicated severe cardiac, pulmonary, hepatic, or renal dysfunction or other serious physical illness. (3) Impaired visual pathways, abnormal stereo visual function, etc. (4) The presence of new infarct foci or secondary hemorrhage and deterioration of the disease.

Design outcomes

Primary

MeasureTime frame
Mean value of oxyhemoglobin concentration;

Secondary

MeasureTime frame
fugl-Meyer assessment;MOCA assessment;

Countries

China

Contacts

Public ContactZulin Dou

The Third Affiliated Hospital of Sun Yat-Sen University

douzul@163.com18922102718

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026